HRT FINANCIAL LP

Position in NVO — Novo Nordisk A S

CIK 1475597 NEW YORK, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,140,183

+$3,915,511 QoQ

Shares Held

148,940

+135.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#176

of 1,348 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $691,078,789 across 12 Drug Manufacturers - General names. NVO ranks #8 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,031,961	$262,087,135
2	ABBV	AbbVie Inc.	702,907	$176,879,517
3	MRK	Merck & Co., Inc.	798,048	$102,549,168
4	LLY	ELI LILLY & Co	38,616	$46,317,192
5	BMY	Bristol Myers Squibb Co	741,187	$42,707,194
6	GSK	GSK plc	603,902	$31,656,542
7	NVS	Novartis AG	89,587	$14,040,074
8	NVO	Novo Nordisk A S This page	148,940	$7,140,183

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,140,183	148,940	+135.0%	Shares	Defined	2026-08-14
2025-12-31	$3,224,672	63,378	-73.7%	Shares	Defined	2026-02-12
2025-09-30	$13,375,087	241,036	+58.9%	Shares	Defined	2025-11-14
2025-06-30	$10,470,748	151,706	+154.7%	Shares	Defined	2025-08-14
2025-03-31	$4,136,124	59,564	+20.4%	Shares	Defined	2025-05-15
2024-12-31	$4,255,839	49,475	+1975.3%	Shares	Defined	2025-02-14
2022-03-31	$264,743	2,384	-85.9%	Shares	Defined	2022-05-16
2021-12-31	$1,896,272	16,931	-52.3%	Shares	Defined	2022-02-14
2021-09-30	$3,405,378	35,469	-0.6%	Shares	Defined	2021-11-15
2021-03-31	$2,406,556	35,695	+195.2%	Shares	Defined	2021-05-17
2020-12-31	$844,556	12,091	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.